Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxd9
|
ENSMUSG00000043342.8 | homeobox D9 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_74698230_74698582 | Hoxd9 | 679 | 0.277969 | 0.74 | 7.5e-11 | Click! |
chr2_74698677_74699049 | Hoxd9 | 1136 | 0.160624 | 0.74 | 1.5e-10 | Click! |
chr2_74699106_74699257 | Hoxd9 | 1454 | 0.121760 | 0.72 | 5.9e-10 | Click! |
chr2_74697897_74698190 | Hoxd9 | 316 | 0.486989 | 0.70 | 3.7e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14347096_14348750 | 20.89 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr17_66869624_66870037 | 14.81 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chr10_54941628_54941779 | 13.81 |
Gm31849 |
predicted gene, 31849 |
115490 |
0.07 |
chr9_89496663_89497009 | 10.60 |
Gm47403 |
predicted gene, 47403 |
63548 |
0.11 |
chr2_34107702_34107910 | 10.57 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
71 |
0.98 |
chr4_73489203_73489506 | 10.37 |
Gm11488 |
predicted gene 11488 |
9123 |
0.21 |
chr15_56344634_56344977 | 9.89 |
Gm49213 |
predicted gene, 49213 |
70208 |
0.13 |
chr4_73774316_73774478 | 9.73 |
Rasef |
RAS and EF hand domain containing |
16205 |
0.16 |
chr18_30378036_30378274 | 9.66 |
Gm7926 |
predicted gene 7926 |
41905 |
0.14 |
chr2_84266260_84266411 | 9.40 |
Gm13711 |
predicted gene 13711 |
51976 |
0.13 |
chr6_58933581_58933791 | 8.98 |
Herc3 |
hect domain and RLD 3 |
26424 |
0.12 |
chr6_112809935_112810331 | 8.91 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19326 |
0.21 |
chr10_29143863_29144732 | 8.90 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr11_96306991_96307195 | 8.78 |
Hoxb5os |
homeobox B5 and homeobox B6, opposite strand |
183 |
0.84 |
chr18_44754019_44754173 | 8.51 |
Mcc |
mutated in colorectal cancers |
29438 |
0.17 |
chr8_12126666_12127044 | 8.10 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
151964 |
0.03 |
chr16_57302914_57303208 | 8.05 |
Tmem30c |
transmembrane protein 30C |
10196 |
0.14 |
chr2_34107198_34107369 | 7.86 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
446 |
0.84 |
chr2_152048577_152049360 | 7.84 |
AA387200 |
expressed sequence AA387200 |
27840 |
0.11 |
chr7_73637071_73637452 | 7.79 |
Gm44737 |
predicted gene 44737 |
6644 |
0.1 |
chr14_34896045_34896643 | 7.74 |
Mir346 |
microRNA 346 |
1735 |
0.44 |
chr12_3236518_3237725 | 7.67 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr8_108481367_108481751 | 7.56 |
Gm39244 |
predicted gene, 39244 |
55388 |
0.16 |
chr15_66239660_66240017 | 7.47 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr4_62612568_62612795 | 7.40 |
Rgs3 |
regulator of G-protein signaling 3 |
6839 |
0.18 |
chr1_30061154_30061322 | 7.24 |
Gm23771 |
predicted gene, 23771 |
75304 |
0.12 |
chr18_81831298_81831489 | 7.18 |
Gm30454 |
predicted gene, 30454 |
18623 |
0.19 |
chrX_102081697_102081848 | 7.13 |
Nhsl2 |
NHS-like 2 |
8830 |
0.13 |
chr7_93062174_93062609 | 7.11 |
Fam181b |
family with sequence similarity 181, member B |
17474 |
0.16 |
chr13_83741584_83742060 | 7.11 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2959 |
0.16 |
chr5_20197195_20197346 | 7.08 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
5299 |
0.26 |
chr10_102238597_102238748 | 7.06 |
Mgat4c |
MGAT4 family, member C |
79593 |
0.1 |
chr17_93676683_93676842 | 7.02 |
Gm50002 |
predicted gene, 50002 |
3903 |
0.28 |
chr12_58067608_58067782 | 7.00 |
Gm46329 |
predicted gene, 46329 |
116484 |
0.06 |
chr2_109743615_109743973 | 6.96 |
Bdnf |
brain derived neurotrophic factor |
34411 |
0.16 |
chr4_76369307_76369458 | 6.92 |
Gm11252 |
predicted gene 11252 |
23772 |
0.21 |
chr9_89497041_89497222 | 6.92 |
Gm47403 |
predicted gene, 47403 |
63253 |
0.11 |
chr2_150735739_150736543 | 6.91 |
Gm28450 |
predicted gene 28450 |
11520 |
0.12 |
chr3_83609415_83609692 | 6.85 |
1700028M03Rik |
RIKEN cDNA 1700028M03 gene |
35431 |
0.18 |
chr16_77851555_77851719 | 6.83 |
Gm17333 |
predicted gene, 17333 |
5033 |
0.28 |
chr2_109678215_109678406 | 6.82 |
Bdnf |
brain derived neurotrophic factor |
1278 |
0.37 |
chr13_60364900_60365094 | 6.78 |
Gm10779 |
predicted gene 10779 |
33548 |
0.15 |
chr9_41834797_41835036 | 6.73 |
Gm35940 |
predicted gene, 35940 |
19312 |
0.15 |
chr1_12690442_12690837 | 6.69 |
Sulf1 |
sulfatase 1 |
1638 |
0.36 |
chr2_45356875_45357110 | 6.66 |
Gm13479 |
predicted gene 13479 |
273 |
0.94 |
chr3_68824497_68825036 | 6.60 |
Gm7270 |
predicted gene 7270 |
21313 |
0.12 |
chr6_55444728_55444879 | 6.59 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
7175 |
0.21 |
chr18_55763354_55763572 | 6.52 |
Gm26959 |
predicted gene, 26959 |
17235 |
0.23 |
chr3_3831527_3831694 | 6.45 |
Gm2071 |
predicted gene 2071 |
2326 |
0.38 |
chr1_12410598_12410778 | 6.45 |
Mir6341 |
microRNA 6341 |
15298 |
0.24 |
chr11_36109270_36109421 | 6.40 |
Gm12126 |
predicted gene 12126 |
28681 |
0.23 |
chr4_71131009_71131663 | 6.32 |
Gm11228 |
predicted gene 11228 |
203 |
0.96 |
chr13_83984413_83984945 | 6.25 |
Gm4241 |
predicted gene 4241 |
3312 |
0.25 |
chr12_48222098_48222420 | 6.20 |
Gm46327 |
predicted gene, 46327 |
174725 |
0.03 |
chr2_80399040_80399219 | 6.16 |
Gm13752 |
predicted gene 13752 |
4232 |
0.23 |
chr10_76157506_76157824 | 6.09 |
Slc5a4a |
solute carrier family 5, member 4a |
10214 |
0.12 |
chr3_79818299_79818691 | 6.08 |
Gm26420 |
predicted gene, 26420 |
16438 |
0.17 |
chr2_169811648_169811846 | 6.07 |
Tshz2 |
teashirt zinc finger family member 2 |
73146 |
0.12 |
chr13_116497636_116498069 | 6.05 |
Gm47912 |
predicted gene, 47912 |
136158 |
0.05 |
chr6_135112396_135112681 | 5.95 |
Gprc5d |
G protein-coupled receptor, family C, group 5, member D |
5708 |
0.14 |
chr5_132068075_132068265 | 5.94 |
Auts2 |
autism susceptibility candidate 2 |
17761 |
0.16 |
chr6_73644786_73645257 | 5.94 |
Gm31747 |
predicted gene, 31747 |
36348 |
0.2 |
chr5_103161672_103161823 | 5.90 |
Mapk10 |
mitogen-activated protein kinase 10 |
44182 |
0.17 |
chr1_19928027_19928238 | 5.89 |
Gm37315 |
predicted gene, 37315 |
137416 |
0.05 |
chr5_149527921_149528686 | 5.87 |
Wdr95 |
WD40 repeat domain 95 |
376 |
0.81 |
chr1_46830172_46830391 | 5.84 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5618 |
0.22 |
chr6_12812173_12812477 | 5.82 |
Gm15529 |
predicted gene 15529 |
45072 |
0.15 |
chr3_18054074_18054270 | 5.81 |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
2 |
0.98 |
chr4_22478892_22479069 | 5.80 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
9386 |
0.17 |
chr1_85089758_85090158 | 5.79 |
Gm10553 |
predicted gene 10553 |
9554 |
0.09 |
chr13_29285173_29285394 | 5.72 |
Gm11364 |
predicted gene 11364 |
48663 |
0.18 |
chr13_95999496_95999647 | 5.70 |
Sv2c |
synaptic vesicle glycoprotein 2c |
9345 |
0.22 |
chr16_59445270_59445421 | 5.67 |
1700022E09Rik |
RIKEN cDNA 1700022E09 gene |
23859 |
0.13 |
chr16_44687184_44688343 | 5.67 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr1_35528071_35528323 | 5.65 |
Gm37068 |
predicted gene, 37068 |
123100 |
0.06 |
chr12_13049781_13049976 | 5.63 |
Gm48209 |
predicted gene, 48209 |
4851 |
0.2 |
chr4_22835787_22836371 | 5.62 |
Gm24078 |
predicted gene, 24078 |
88948 |
0.09 |
chr18_44540176_44540327 | 5.60 |
Mcc |
mutated in colorectal cancers |
20735 |
0.24 |
chr13_28812178_28812329 | 5.59 |
Gm17528 |
predicted gene, 17528 |
14870 |
0.19 |
chr10_106469332_106470360 | 5.58 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
493 |
0.82 |
chr2_106487894_106488077 | 5.57 |
Gm14015 |
predicted gene 14015 |
35118 |
0.19 |
chr18_37217169_37217576 | 5.56 |
Gm10544 |
predicted gene 10544 |
38850 |
0.08 |
chr4_76144419_76144591 | 5.56 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
10362 |
0.31 |
chr4_72384628_72385513 | 5.55 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr9_79690187_79690494 | 5.55 |
4930562D21Rik |
RIKEN cDNA 4930562D21 gene |
1564 |
0.4 |
chr16_91140532_91140860 | 5.55 |
Gm49612 |
predicted gene, 49612 |
5220 |
0.12 |
chr13_83734346_83734573 | 5.55 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1893 |
0.22 |
chr15_103018773_103018952 | 5.54 |
Hoxc4 |
homeobox C4 |
72 |
0.93 |
chr6_52226675_52226926 | 5.53 |
Hoxa9 |
homeobox A9 |
570 |
0.41 |
chr2_53947716_53947867 | 5.52 |
Rprm |
reprimo, TP53 dependent G2 arrest mediator candidate |
137761 |
0.05 |
chr3_40070102_40070729 | 5.51 |
Gm42785 |
predicted gene 42785 |
246838 |
0.02 |
chr8_109232343_109232696 | 5.48 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
17347 |
0.26 |
chr13_75992259_75992662 | 5.46 |
Spata9 |
spermatogenesis associated 9 |
24713 |
0.1 |
chr15_63442442_63442682 | 5.46 |
Gm41335 |
predicted gene, 41335 |
37046 |
0.15 |
chr1_17145272_17145872 | 5.46 |
Gdap1 |
ganglioside-induced differentiation-associated-protein 1 |
104 |
0.97 |
chr10_91859325_91859494 | 5.46 |
Gm31592 |
predicted gene, 31592 |
29420 |
0.24 |
chr2_107935313_107935699 | 5.46 |
Gm23439 |
predicted gene, 23439 |
48867 |
0.19 |
chr15_60967833_60968237 | 5.45 |
Gm48951 |
predicted gene, 48951 |
29399 |
0.17 |
chr4_21932308_21932628 | 5.44 |
Faxc |
failed axon connections homolog |
1111 |
0.54 |
chr13_83985066_83985623 | 5.44 |
Gm4241 |
predicted gene 4241 |
2647 |
0.28 |
chr6_108145994_108146240 | 5.43 |
Sumf1 |
sulfatase modifying factor 1 |
1422 |
0.44 |
chr4_93437432_93437583 | 5.43 |
Tusc1 |
tumor suppressor candidate 1 |
101996 |
0.07 |
chr6_52230876_52231070 | 5.41 |
Hoxa9 |
homeobox A9 |
116 |
0.83 |
chr8_26852335_26852486 | 5.38 |
2310008N11Rik |
RIKEN cDNA 2310008N11 gene |
10411 |
0.19 |
chr14_68981312_68981674 | 5.37 |
Stc1 |
stanniocalcin 1 |
47745 |
0.13 |
chr1_47163860_47164031 | 5.37 |
Gm28826 |
predicted gene 28826 |
10484 |
0.28 |
chr1_61407385_61407544 | 5.37 |
9530026F06Rik |
RIKEN cDNA 9530026F06 gene |
29032 |
0.14 |
chr2_163289163_163289359 | 5.33 |
Tox2 |
TOX high mobility group box family member 2 |
31117 |
0.16 |
chr10_51610178_51610335 | 5.32 |
Fam162b |
family with sequence similarity 162, member B |
19739 |
0.11 |
chr15_35533292_35533493 | 5.32 |
Gm48966 |
predicted gene, 48966 |
34851 |
0.15 |
chr8_61452047_61452198 | 5.32 |
Cbr4 |
carbonyl reductase 4 |
35612 |
0.16 |
chr16_77422153_77422336 | 5.32 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
424 |
0.74 |
chr1_106598312_106598468 | 5.31 |
Gm37053 |
predicted gene, 37053 |
8480 |
0.22 |
chr17_63712992_63713143 | 5.31 |
Gm9300 |
predicted gene 9300 |
10577 |
0.25 |
chr16_63747767_63748162 | 5.30 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr2_16450899_16451272 | 5.27 |
Plxdc2 |
plexin domain containing 2 |
93968 |
0.1 |
chr3_105569533_105569784 | 5.27 |
Gm43847 |
predicted gene 43847 |
66751 |
0.09 |
chr18_55763810_55763961 | 5.27 |
Gm26959 |
predicted gene, 26959 |
17657 |
0.23 |
chr9_23378360_23378672 | 5.23 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr13_84064676_84065083 | 5.23 |
Gm17750 |
predicted gene, 17750 |
107 |
0.97 |
chr10_17411357_17411707 | 5.22 |
Gm47760 |
predicted gene, 47760 |
78655 |
0.09 |
chr1_163898263_163898466 | 5.20 |
Scyl3 |
SCY1-like 3 (S. cerevisiae) |
30736 |
0.17 |
chr15_88315161_88315318 | 5.18 |
B230214G05Rik |
RIKEN cDNA B230214G05 gene |
365 |
0.51 |
chr7_51759887_51760067 | 5.17 |
Gm29296 |
predicted gene 29296 |
12749 |
0.17 |
chr19_17650891_17651137 | 5.16 |
Gm17819 |
predicted gene, 17819 |
41749 |
0.19 |
chr9_43768811_43769153 | 5.15 |
Gm30015 |
predicted gene, 30015 |
22882 |
0.14 |
chr12_39073634_39073815 | 5.15 |
Gm19563 |
predicted gene, 19563 |
75070 |
0.09 |
chr6_109874355_109874582 | 5.14 |
Gm44162 |
predicted gene, 44162 |
158921 |
0.04 |
chr3_21891883_21892491 | 5.13 |
7530428D23Rik |
RIKEN cDNA 7530428D23 gene |
91414 |
0.08 |
chr17_68490430_68490581 | 5.13 |
Gm15974 |
predicted gene 15974 |
118695 |
0.06 |
chr4_73488674_73489118 | 5.10 |
Gm11488 |
predicted gene 11488 |
9581 |
0.21 |
chr2_136051128_136051415 | 5.10 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
968 |
0.6 |
chr8_29978910_29979061 | 5.08 |
Gm45492 |
predicted gene 45492 |
102975 |
0.08 |
chr10_99812195_99812400 | 5.07 |
Csl |
citrate synthase like |
52639 |
0.11 |
chr13_11099319_11099546 | 5.06 |
Gm47486 |
predicted gene, 47486 |
125009 |
0.06 |
chr10_86295514_86296153 | 5.05 |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
4539 |
0.27 |
chr3_105530739_105530942 | 5.04 |
Gm43847 |
predicted gene 43847 |
27933 |
0.18 |
chr10_111923671_111923831 | 5.03 |
Gm47880 |
predicted gene, 47880 |
34737 |
0.12 |
chr1_81745106_81745257 | 5.03 |
Gm5530 |
predicted gene 5530 |
2212 |
0.41 |
chr11_110649930_110650081 | 5.02 |
Gm11682 |
predicted gene 11682 |
105498 |
0.08 |
chr1_111833741_111833937 | 5.02 |
Gm37934 |
predicted gene, 37934 |
16 |
0.98 |
chr16_74796393_74796544 | 5.00 |
Gm49674 |
predicted gene, 49674 |
79470 |
0.11 |
chr15_13172407_13172558 | 5.00 |
Cdh6 |
cadherin 6 |
1193 |
0.63 |
chr2_38132297_38132687 | 5.00 |
Gm44291 |
predicted gene, 44291 |
25196 |
0.17 |
chr1_51697455_51697651 | 4.99 |
Gm28055 |
predicted gene 28055 |
347 |
0.91 |
chr5_9345422_9345573 | 4.99 |
Gm15733 |
predicted gene 15733 |
8262 |
0.2 |
chr2_21010157_21010628 | 4.97 |
Gm13375 |
predicted gene 13375 |
41338 |
0.14 |
chr3_50044774_50044968 | 4.97 |
Gm37826 |
predicted gene, 37826 |
15202 |
0.23 |
chr3_125404522_125404673 | 4.97 |
Ndst4 |
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4 |
507 |
0.89 |
chr11_17811914_17812084 | 4.97 |
Etaa1 |
Ewing tumor-associated antigen 1 |
141876 |
0.04 |
chr18_13397132_13397486 | 4.97 |
Gm50093 |
predicted gene, 50093 |
25220 |
0.24 |
chr15_53145899_53146294 | 4.96 |
Ext1 |
exostosin glycosyltransferase 1 |
38228 |
0.23 |
chr8_10701738_10702010 | 4.96 |
Gm44785 |
predicted gene 44785 |
11708 |
0.12 |
chr2_133666827_133667000 | 4.94 |
Gm25258 |
predicted gene, 25258 |
82492 |
0.1 |
chr6_108919507_108919818 | 4.94 |
Gm6749 |
predicted pseudogene 6749 |
37658 |
0.18 |
chr14_93009566_93009910 | 4.94 |
Gm48963 |
predicted gene, 48963 |
117036 |
0.06 |
chr4_105475089_105475539 | 4.94 |
Gm12723 |
predicted gene 12723 |
35918 |
0.21 |
chr6_138420273_138420927 | 4.93 |
Lmo3 |
LIM domain only 3 |
852 |
0.59 |
chr7_51772714_51772887 | 4.92 |
Gm29296 |
predicted gene 29296 |
74 |
0.97 |
chr9_15964185_15964748 | 4.92 |
Fat3 |
FAT atypical cadherin 3 |
6644 |
0.29 |
chr10_18744312_18744482 | 4.91 |
Arfgef3 |
ARFGEF family member 3 |
448 |
0.57 |
chr7_117139806_117140098 | 4.91 |
Gm39075 |
predicted gene, 39075 |
89655 |
0.09 |
chrX_110318504_110318684 | 4.90 |
Gm7134 |
predicted gene 7134 |
54159 |
0.18 |
chr14_122247594_122247754 | 4.89 |
Clybl |
citrate lyase beta like |
10367 |
0.19 |
chr8_36195680_36195857 | 4.89 |
Gm35520 |
predicted gene, 35520 |
7396 |
0.16 |
chr3_30452791_30452942 | 4.89 |
Gm37024 |
predicted gene, 37024 |
35560 |
0.14 |
chr7_65049359_65049510 | 4.88 |
Gm25249 |
predicted gene, 25249 |
92858 |
0.07 |
chr2_108691713_108692000 | 4.88 |
Gm13914 |
predicted gene 13914 |
42346 |
0.19 |
chr1_44580407_44580702 | 4.87 |
Gm37626 |
predicted gene, 37626 |
19669 |
0.19 |
chr10_30327889_30328266 | 4.86 |
Gm4780 |
predicted gene 4780 |
44841 |
0.17 |
chrX_105392063_105392243 | 4.86 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
377 |
0.85 |
chr3_49592802_49593003 | 4.86 |
Gm38261 |
predicted gene, 38261 |
10659 |
0.16 |
chr2_56454778_56454958 | 4.86 |
Mir195b |
microRNA 195b |
330943 |
0.01 |
chr1_47545788_47545965 | 4.85 |
Gm37196 |
predicted gene, 37196 |
60120 |
0.11 |
chr3_88222441_88222775 | 4.85 |
Gm3764 |
predicted gene 3764 |
56 |
0.93 |
chr16_63084175_63084358 | 4.85 |
Gm49621 |
predicted gene, 49621 |
27424 |
0.22 |
chr7_65484213_65484369 | 4.85 |
Gm44792 |
predicted gene 44792 |
3070 |
0.28 |
chr12_117728160_117728414 | 4.84 |
Gm18955 |
predicted gene, 18955 |
4315 |
0.24 |
chr3_30228229_30228527 | 4.83 |
Gm38197 |
predicted gene, 38197 |
684 |
0.67 |
chr5_132034084_132034283 | 4.83 |
Auts2 |
autism susceptibility candidate 2 |
5557 |
0.15 |
chr3_56955404_56955772 | 4.83 |
Gm22269 |
predicted gene, 22269 |
98562 |
0.08 |
chr5_103938647_103939049 | 4.80 |
Klhl8 |
kelch-like 8 |
27589 |
0.12 |
chr5_131645657_131645846 | 4.79 |
Gm43483 |
predicted gene 43483 |
2944 |
0.17 |
chr17_31432845_31433214 | 4.78 |
Pde9a |
phosphodiesterase 9A |
42 |
0.96 |
chr10_99860785_99860939 | 4.78 |
Gm47579 |
predicted gene, 47579 |
5158 |
0.25 |
chr7_61877670_61878066 | 4.78 |
Mir344 |
microRNA 344 |
4 |
0.96 |
chr16_42276867_42277080 | 4.77 |
Gap43 |
growth associated protein 43 |
901 |
0.65 |
chr5_74433093_74433271 | 4.77 |
Gm43167 |
predicted gene 43167 |
2077 |
0.32 |
chr6_22688875_22689026 | 4.75 |
Gm8927 |
predicted gene 8927 |
14486 |
0.19 |
chrX_16910312_16910501 | 4.75 |
Ndp |
Norrie disease (pseudoglioma) (human) |
1368 |
0.59 |
chr15_25761802_25762209 | 4.74 |
Myo10 |
myosin X |
3220 |
0.3 |
chr4_110120761_110121239 | 4.73 |
Elavl4 |
ELAV like RNA binding protein 4 |
102148 |
0.07 |
chr2_136108035_136108369 | 4.73 |
Gm14218 |
predicted gene 14218 |
28804 |
0.19 |
chr2_179522227_179522422 | 4.72 |
Cdh4 |
cadherin 4 |
78091 |
0.1 |
chr6_42710407_42710569 | 4.72 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
400 |
0.72 |
chr2_155863311_155863718 | 4.72 |
Uqcc1 |
ubiquinol-cytochrome c reductase complex assembly factor 1 |
11822 |
0.11 |
chr1_84086467_84086780 | 4.71 |
Pid1 |
phosphotyrosine interaction domain containing 1 |
33370 |
0.18 |
chr1_54556878_54557293 | 4.71 |
Pgap1 |
post-GPI attachment to proteins 1 |
542 |
0.76 |
chr1_161689166_161689317 | 4.69 |
Gm37638 |
predicted gene, 37638 |
24464 |
0.16 |
chr1_57875514_57875995 | 4.69 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
26317 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.2 | 8.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
2.0 | 13.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.9 | 5.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.7 | 5.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.5 | 6.2 | GO:0007412 | axon target recognition(GO:0007412) |
1.4 | 11.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.3 | 3.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.3 | 3.9 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.3 | 1.3 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.2 | 3.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.2 | 2.4 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.2 | 3.6 | GO:0015791 | polyol transport(GO:0015791) |
1.1 | 5.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 5.7 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.1 | 5.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.1 | 7.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 4.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.0 | 2.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.0 | 3.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.0 | 3.0 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.0 | 4.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.0 | 4.0 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.0 | 3.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.0 | 3.0 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.0 | 5.0 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.0 | 3.0 | GO:0031296 | B cell costimulation(GO:0031296) |
1.0 | 16.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.9 | 3.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.9 | 2.8 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.9 | 2.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.9 | 2.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.9 | 1.8 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.9 | 2.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.9 | 2.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.9 | 3.5 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.9 | 3.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.8 | 1.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.8 | 0.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.8 | 4.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.8 | 0.8 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.8 | 2.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.8 | 2.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 2.3 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.8 | 1.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.8 | 0.8 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.7 | 4.4 | GO:0035989 | tendon development(GO:0035989) |
0.7 | 3.6 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.7 | 2.2 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 0.7 | GO:0035106 | operant conditioning(GO:0035106) |
0.7 | 2.8 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.7 | 2.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.7 | 6.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.7 | 1.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.7 | 2.1 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.7 | 4.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.7 | 2.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.7 | 7.4 | GO:0060013 | righting reflex(GO:0060013) |
0.7 | 2.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.6 | 2.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 2.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.6 | 11.7 | GO:0060065 | uterus development(GO:0060065) |
0.6 | 1.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 3.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.6 | 1.8 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.6 | 1.8 | GO:0061743 | motor learning(GO:0061743) |
0.6 | 3.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.6 | 10.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.6 | 4.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.6 | 2.9 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.6 | 4.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 3.4 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.6 | 1.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.6 | 0.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 2.7 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.5 | 1.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.5 | 1.6 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.5 | 1.1 | GO:0010963 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.5 | 1.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 1.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.5 | 1.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.5 | 2.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 1.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 1.5 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.5 | 1.5 | GO:0072017 | distal tubule development(GO:0072017) |
0.5 | 3.0 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 3.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 2.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 2.0 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.5 | 2.4 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.5 | 1.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.5 | 0.5 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.5 | 1.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 1.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.5 | 0.9 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.5 | 1.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 1.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 1.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 1.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.5 | 2.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.5 | 9.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.4 | 2.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.4 | 1.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 1.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 1.8 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.4 | 0.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 3.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 1.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 1.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.4 | 1.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 4.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.4 | 2.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 0.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 2.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 1.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 0.8 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 4.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 1.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 2.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.4 | 1.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.4 | 1.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 0.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 3.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 4.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 0.8 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.4 | 0.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 2.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 0.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.4 | 1.2 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.4 | 1.5 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 1.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.4 | 2.6 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.4 | 3.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 29.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 3.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 5.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 3.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 0.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 0.4 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.4 | 1.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.1 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.4 | 1.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 1.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 2.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.4 | 1.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.4 | 1.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.3 | 0.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 1.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 1.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.3 | 1.7 | GO:0015808 | L-alanine transport(GO:0015808) |
0.3 | 1.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 1.7 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 2.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 1.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 3.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.3 | 1.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 1.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 1.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 1.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 2.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 1.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 0.6 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 0.6 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 0.3 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.3 | 1.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 1.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 0.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 1.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 0.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 2.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.6 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.3 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 1.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 1.2 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.3 | 1.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 1.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 1.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.9 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 1.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 0.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.3 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.3 | 0.6 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 0.3 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.3 | 0.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 2.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 1.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 0.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.3 | 1.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.3 | 0.3 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 0.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 0.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 0.8 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.3 | 0.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 0.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.3 | 1.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 0.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 0.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 1.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.3 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.3 | 1.0 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.3 | 0.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.3 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 1.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 1.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 1.0 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.5 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 1.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 0.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.2 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.2 | 0.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.9 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 0.7 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.2 | 3.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.2 | 1.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 1.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.2 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 2.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.5 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.2 | 0.5 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 0.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 4.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 2.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 1.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 1.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.4 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 1.0 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 1.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.8 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 0.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 1.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 2.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.2 | GO:0046958 | nonassociative learning(GO:0046958) |
0.2 | 0.6 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 4.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 0.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 0.4 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 0.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 1.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.6 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.2 | 1.5 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 3.6 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 1.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.2 | 1.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.9 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 0.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.7 | GO:0060004 | reflex(GO:0060004) |
0.2 | 1.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 0.2 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.2 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 0.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.2 | 0.4 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.2 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 3.7 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.2 | 1.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.2 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.2 | 0.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.5 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.3 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 0.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.2 | 0.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 1.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 0.7 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.2 | 1.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.2 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 0.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 1.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 1.1 | GO:0043584 | nose development(GO:0043584) |
0.2 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.6 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 1.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.2 | 2.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.2 | 0.5 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 2.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 1.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 6.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.1 | 0.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.4 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.3 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.6 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
0.1 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 0.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 1.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.4 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 2.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.4 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 1.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 1.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.1 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.1 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 1.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.9 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 1.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.1 | 0.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.4 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.3 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 5.9 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.7 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.8 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.2 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.2 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 1.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.6 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.8 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.5 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 2.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.1 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.3 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 1.4 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.2 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 2.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.3 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.2 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.5 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 1.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.5 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.4 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.2 | GO:0003157 | endocardium development(GO:0003157) |
0.1 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.3 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 1.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 5.5 | GO:0007411 | axon guidance(GO:0007411) |
0.1 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.1 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.1 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.5 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.1 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
0.1 | 0.1 | GO:0048857 | neural nucleus development(GO:0048857) |
0.1 | 1.0 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.5 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.7 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.1 | GO:0001840 | neural plate development(GO:0001840) |
0.1 | 0.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.1 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.1 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.3 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.0 | 1.6 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.3 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.8 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.0 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.4 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.0 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.1 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.2 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.2 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.1 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.0 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.0 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.0 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.1 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.0 | 0.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.0 | GO:0042583 | chromaffin granule(GO:0042583) |
1.0 | 4.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 5.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 6.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.9 | 9.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.9 | 6.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.8 | 2.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.8 | 2.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.7 | 6.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 7.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 2.8 | GO:1990357 | terminal web(GO:1990357) |
0.7 | 4.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.7 | 4.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 6.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.6 | 1.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 3.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 6.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 5.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 1.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.4 | 4.8 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 2.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 6.3 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 15.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 1.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 8.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 1.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 8.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 1.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 3.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 1.8 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 5.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 1.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 0.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 4.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 1.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 3.4 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.9 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 2.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 2.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 1.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 1.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.0 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.8 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 7.8 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 18.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.5 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 3.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 7.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.3 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 5.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.7 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.5 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 2.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.8 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.3 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 1.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 1.0 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 1.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 2.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 1.1 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.3 | 11.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.2 | 6.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
2.2 | 4.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
2.0 | 5.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.9 | 5.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.7 | 6.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.5 | 6.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.3 | 1.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 3.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.2 | 4.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.2 | 9.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.1 | 7.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.0 | 3.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.0 | 3.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.9 | 4.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 2.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 2.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.8 | 3.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.8 | 3.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.8 | 0.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.7 | 2.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 3.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 1.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.6 | 1.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.6 | 3.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 1.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 2.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.6 | 3.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 3.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 2.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 2.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 12.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.5 | 0.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.5 | 1.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.5 | 1.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 2.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.5 | 7.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 1.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.5 | 2.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 1.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 3.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 1.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 0.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.5 | 2.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 2.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 1.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 1.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 2.1 | GO:0034580 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.4 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 2.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 3.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 1.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.4 | 2.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 1.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.4 | 1.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 1.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.3 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 0.9 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 4.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 2.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.3 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 1.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 3.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 1.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 2.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 2.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 1.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 1.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 1.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 1.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 1.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 2.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 4.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 1.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 1.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.6 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.8 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 4.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 1.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 1.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 2.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 0.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 5.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 5.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 2.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 2.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 2.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.7 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 1.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 1.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 3.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 6.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 2.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 1.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 2.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 2.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 3.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 5.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 1.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.4 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 5.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 3.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 1.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 1.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 1.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 2.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 1.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 3.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 1.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 4.7 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 1.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 1.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.0 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 1.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 1.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 2.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 2.4 | GO:0018721 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 1.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.4 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.0 | 0.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.2 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.2 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 5.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 9.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 4.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 5.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 6.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 4.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 7.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 0.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 3.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 3.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 3.0 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 4.9 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 4.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.7 | 15.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 7.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 5.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 5.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.5 | 6.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 1.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.4 | 5.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 4.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 3.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 2.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 8.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 2.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 9.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 10.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 5.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 3.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 4.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 3.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 0.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 2.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.4 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 3.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 2.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.4 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 2.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 4.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 1.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.0 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |